DeviceTalks Weekly, powered by MassDevice
In this week’s episode of DeviceTalks Weekly we review the Medical Design & Outsourcing’s Women in Medtech issue.
Senior Editor Danielle Kirsh will share her takeways from the issue, which she spearheaded with managing editor Nancy Crotti.
We’ll also include excerpts of interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences and Naomi Murray, Stryker’s director of advanced operations. Patty Post, CEO of Checkable Medical, is our opening keynote.
In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?
Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens.
Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.
